An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
07 2021
Historique:
entrez: 30 7 2021
pubmed: 31 7 2021
medline: 4 8 2021
Statut: ppublish

Résumé

An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) spread from one inpatient in a secondary care hospital to three primary care facilities, resulting in 58 infections including 18 deaths in patients and 45 infections in healthcare workers (HCW). Only one of the deceased cases was fully vaccinated. Transmission occurred despite the use of personal protective equipment by the HCW, as advised in national guidelines, and a high two-dose COVID-19 vaccination coverage among permanent staff members in the COVID-19 cohort ward.

Identifiants

pubmed: 34328076
doi: 10.2807/1560-7917.ES.2021.26.30.2100636
pmc: PMC8323455
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413740
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32817231
Lancet Respir Med. 2021 Jul;9(7):687-689
pubmed: 33965002
Nat Med. 2020 Nov;26(11):1714-1719
pubmed: 32943787
Lancet Infect Dis. 2021 May;21(5):629-636
pubmed: 33545090
Clin Infect Dis. 2021 Jun 15;72(12):2225-2240
pubmed: 33104186
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
N Engl J Med. 2021 Aug 12;385(7):585-594
pubmed: 34289274
Int J Occup Med Environ Health. 2021 May 27;34(2):239-249
pubmed: 33847307
Ann Intern Med. 2021 Jan;174(1):69-79
pubmed: 32941052

Auteurs

Iivo Hetemäki (I)

Infectious Diseases Unit, Kanta-Häme Central Hospital, Hämeenlinna, Finland.
Translational Immunology Program, Helsinki University and Helsinki University Central Hospital, Helsinki, Finland.

Sohvi Kääriäinen (S)

ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden.
Finnish Institute for Health and Welfare, Helsinki, Finland.

Pirjo Alho (P)

Infectious Diseases Unit, Kanta-Häme Central Hospital, Hämeenlinna, Finland.

Janne Mikkola (J)

Infectious Diseases Unit, Kanta-Häme Central Hospital, Hämeenlinna, Finland.

Carita Savolainen-Kopra (C)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Niina Ikonen (N)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Hanna Nohynek (H)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Outi Lyytikäinen (O)

Finnish Institute for Health and Welfare, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH